🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseEfinopegdutide MASH data — July 2024 Page 7

Efinopegdutide MASH data — July 2024

KarenAZ_mom Thu, May 30, 2024 at 2:14 PM 39 replies 2,830 viewsPage 7 of 8
FitDadDave
Member
534
2,678
Jul 2024
Minneapolis, MN
Aug 6, 2024 at 12:51 PM#31
PeptideSynthNJ said:
Say what you would expect to see if you were wrong, before you look.

This answered a question I did not know how to ask.

9 7Dr.NephBHM_UK, kim_atl_prep, sarah_TO and 6 others
Reply Quote Save Share Report
EndoResFellow
Member
456
2,345
Sep 2024
Baltimore, MD
Aug 11, 2024 at 5:43 PM#32

Adding the clinical framing, because it changes how the question reads. The distinction that resolves most of these threads is between what is true on average and what is true for one person. Both are real; they answer different questions and get quoted as if they were the same one.

10 8TinaHashiRN, robert_kc, dan_philly and 7 others
Reply Quote Save Share Report
greg_boulder
Member
345
1,567
Jul 2024
Boulder, CO
Aug 16, 2024 at 10:32 PM#33
EndoResFellow said:
The distinction that resolves most of these threads is between what is true on average and what is true for one person.

Can confirm. Same sequence, different timescale. I had assumed I was the exception until I read this.

11 9Dr.DermMIA, fiona_VT, denise_HTX and 8 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
LindaRN_retired
Member
189
890
Dec 2024
Sarasota, FL
Aug 22, 2024 at 3:18 AM#34
EndoResFellow said:
The distinction that resolves most of these threads is between what is true on average and what is true for one person.

There is a second half to this that has not been said yet. Start from the measurement rather than the conclusion. Almost every disagreement here turns out to be two people measuring different things and comparing the numbers anyway.

12 10LondonLisa, mike_nyc, VendorMark and 9 others
Reply Quote Save Share Report
Dr.PulmRoch
Member
456
2,345
Jun 2024
Rochester, MN
Aug 27, 2024 at 8:01 AM#35

One concrete data point for the thread. Keep the original post as written when you update it, and add the correction underneath. An edited-away mistake is invisible to the next person who makes it.

Happy to go further on any of that.

13 11KristenIndy, MarkLI_maint, Dr.PeteFamMed and 10 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register